CTC S.A. (CTCA3) Main Indicators
Basic Data - CTCA3
Company | CTC S.A. |
Corporate Name | CTC - CENTRO DE TECNOLOGIA CANAVIEIRA S.A. |
Registration Status | ATIVO |
Issuer Status | FASE OPERACIONAL |
Listing Segment | Bovespa Mais |
Activity | Com sua atuação em biotecnologia e melhoramento genético o CTC busca busca promover o aumento da produtividade. a redução de custos e soluções agrícolas e industriais para o setor sucroenergético. |
Share | CTCA3 |
Quote Date | NA |
Share Type | ON |
Last Closing | NA |
Quotation Factor | NA |
Financial Volume | NA |
Last Statement | ITR - 09/30/2024 |
Sector | Consumo não Cíclico |
Subsector | Agropecuária |
Segment | Agricultura |
Participation Indexes | - |
Updated 11/21/2024 |
Relative Prices - CTCA3
Price/Earnings | 0.00 |
Price/SBV | 0.00 |
Price/Net Sales | 0.00 |
Price/CFO | 0.00 |
Price/FCF | 0.00 |
Price/Total Assets | 0.00 |
Price/EBIT | 0.00 |
Price/Working Capital | 0.00 |
Price/NCAV | 0.00 |
EV/EBIT | NA |
EV/EBITDA | NA |
EV/Net Sales | NA |
EV/CFO | NA |
EV/FCF | NA |
EV/Total Assets | NA |
Company Market Cap | NA |
Enterprise Value | NA |
Current Financial Statement Date | 09/30/2024 |
Current Share Price | R$ 0.00 |
Share Price Date | //0 |
Dividend Yield | 0.00% |
Updated 11/21/2024 |
Income Statement - CTCA3
Net Revenue | R$ 400.81 M |
Gross Result | R$ 277.57 M |
EBIT | R$ 155.56 M |
Depreciation and Amortization | - R$ 39.91 M |
EBITDA | R$ 195.47 M |
Net Profit | R$ 163.91 M |
Net Profit/Share | R$ 0.51 |
Updated 11/14/2024 |
Net Revenue | R$ 100.13 M |
Gross Result | R$ 69.76 M |
EBIT | R$ 32.16 M |
Depreciation and Amortization | - R$ 9.88 M |
EBITDA | R$ 42.04 M |
Net Profit | R$ 48.03 M |
Profit/Share | R$ 0.15 |
Updated 11/14/2024 |
Price and Volume Behavior - CTCA3
There are no quotes for this ticker.
Returns and Margins - CTCA3
Return on Initial Tangible Capital | 28.63% |
Return on Initial Invested Capital | 13.73% |
Pre-Tax Return on Initial Tangible Capital | 43.38% |
Pre-Tax Return on Initial Invested Capital | 20.81% |
Return on Initial Shareholder´s Equity | 17.55% |
Return on Initial Asset | 15.88% |
Gross Margin | 69.25% |
Net Margin | 40.89% |
EBIT Margin | 38.81% |
EBITDA Margin | 48.77% |
Initial Asset Turnover | 0.39 |
Financial Leverage | 1.23 |
Liabilities/Net Worth | 0.23 |
Net Debt/EBITDA | -0.36 |
Updated 11/14/2024 |
Balance Sheet - CTCA3
Cash and Cash Equivalents | R$ 246.08 M |
Total Assets | R$ 1.31 B |
Short-Term Debt | R$ 12.85 M |
Long-Term Debt | R$ 162.41 M |
Gross Debt | R$ 175.26 M |
Net Debt | - R$ 70.82 M |
Shareholder´s Equity | R$ 1.07 B |
Share Book Value | R$ 3.32 |
Common Shares | 320,748,000 |
Preferred Shares | 0 |
Total | 320,748,000 |
Common Shares in Treasury | 0 |
Preferred Shares in Treasury | 0 |
Total in Treasury | 0 |
Common Shares (Except Treasury) | 320,748,000 |
Preferred Shares (Except Treasury) | 0 |
Total (Except Treasury) | 320,748,000 |
Updated 11/14/2024 |
Cash Flow - CTCA3
Operating Cash Flow | R$ 252.61 M |
Cash Flow from Investments | - R$ 309.46 M |
Financing Cash Flow | R$ 83.63 M |
Increase (Reduction) in Cash and Equivalents | R$ 26.56 M |
Updated 11/14/2024 |
Operating Cash Flow | R$ 100.12 M |
Cash Flow from Investments | - R$ 35.89 M |
Financing Cash Flow | R$ 20.32 M |
Increase (Reduction) in Cash and Equivalents | R$ 84.49 M |
Updated 11/14/2024 |
Experimental - CTCA3
CAPEX 3 months | R$ 0.00 |
Free Cash Flow 3 months | R$ 61.11 M |
CAPEX 12 months | R$ 382.07 M |
Free Cash Flow 12 months | R$ 226.38 M |
Updated 11/14/2024 |
Quote Chart - CTCA3
There are no quotes for this ticker.